The current study was conducted to evaluate the effects of zinc supplementation on endocrine outcomes, biomarkers of inflammation, and oxidative stress in patients with polycystic ovary syndrome (PCOS). This study was a randomized double-blind, placebo-controlled trial. Forty-eight women (18–40 years) with PCOS diagnosed according to Rotterdam criteria were randomly assigned to receive either 220 mg zinc sulfate (containing 50 mg zinc) (group 1; n = 24) and/or placebo (group 2; n = 24) for 8 weeks. Hormonal profiles, biomarkers of inflammation, and oxidative stress were measured at study baseline and after 8-week intervention. After 8 weeks of intervention, alopecia (41.7 vs. 12.5 %, P = 0.02) decreased compared with the placebo. Additionally, patients who received zinc supplements had significantly decreased hirsutism (modified Ferriman-Gallwey scores) (−1.71 ± 0.99 vs. −0.29 ± 0.95, P < 0.001) and plasma malondialdehyde (MDA) levels (−0.09 ± 1.31 vs. +2.34 ± 5.53 μmol/L, P = 0.04) compared with the placebo. A trend toward a significant effect of zinc intake on reducing high-sensitivity C-reactive protein (hs-CRP) levels (P = 0.06) was also observed. We did observe no significant changes of zinc supplementation on hormonal profiles, inflammatory cytokines, and other biomarkers of oxidative stress. In conclusion, using 50 mg/day elemental zinc for 8 weeks among PCOS women had beneficial effects on alopecia, hirsutism, and plasma MDA levels; however, it did not affect hormonal profiles, inflammatory cytokines, and other biomarkers of oxidative stress.
This is a preview of subscription content, log in to check access.
The current study was supported by a grant from the Vice-chancellor for Research, AUMS, and Iran. The authors would like to thank the staff of Kosar Clinic (Arak, Iran) for their assistance in this project.
Conflict of Interest
The authors declare that they have no competing interests.
Z.A. contributed in the conception, design, statistical analysis, and drafting of the manuscript. M.J., F.F., F.B., R.T., and M.M. contributed in data collection and manuscript drafting. Z.A. supervised the study. All authors approved the final version for submission.
The study was supported by a grant (no. 93164) from Arak University of Medical Sciences.
Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, Norman RJ, Costello MF (2011) Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 195(6):S65–112CrossRefPubMedGoogle Scholar
Scicchitano P, Dentamaro I, Carbonara R, Bulzis G, Dachille A, Caputo P, Riccardi R, Locorotondo M, Mandurino C, Matteo Ciccone M (2012) Cardiovascular risk in women with PCOS. Int J Endocrinol Metab 10(4):611–618CrossRefPubMedPubMedCentralGoogle Scholar
Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S (2011) Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertil Steril 95(1):310–313CrossRefPubMedGoogle Scholar
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7(4):219–231CrossRefPubMedGoogle Scholar
Alpanes M, Luque-Ramirez M, Martinez-Garcia MA, Fernandez-Duran E, Alvarez-Blasco F, Escobar-Morreale HF (2015) Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertil Steril 103(3):795–801 e792CrossRefPubMedGoogle Scholar
Su C, Chen M, Huang H, Lin J (2015) Testosterone enhances lipopolysaccharide-induced interleukin-6 and macrophage chemotactic protein-1 expression by activating the extracellular signal-regulated kinase 1/2/nuclear factor-kappaB signalling pathways in 3T3-L1 adipocytes. Mol Med Rep 12(1):696–704PubMedGoogle Scholar
Nasiri N, Moini A, Eftekhari-Yazdi P, Karimian L, Salman-Yazdi R, Zolfaghari Z, Arabipoor A (2015) Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 184:112–116CrossRefPubMedGoogle Scholar
Foresta C, Garolla A, Cosci I, Menegazzo M, Ferigo M, Gandin V, De Toni L (2014) Role of zinc trafficking in male fertility: from germ to sperm. Hum Reprod 29(6):1134–1145CrossRefPubMedGoogle Scholar
Prasad AS (2014) Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging. J Trace Elem Med Biol 28(4):364–371CrossRefPubMedGoogle Scholar
Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S (2015) Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med 13(1):1–8PubMedPubMedCentralGoogle Scholar
Zheng G, Wang L, Guo Z, Sun L, Wang C, Zuo Z, Qiu H (2015) Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Biol Trace Elem Res. [Epub ahead of print]Google Scholar
Guler I, Himmetoglu O, Turp A, Erdem A, Erdem M, Onan MA, Taskiran C, Taslipinar MY, Guner H (2014) Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biol Trace Elem Res 158(3):297–304CrossRefPubMedGoogle Scholar
Michaelsson G, Vahlquist A, Juhlin L (1977) Serum zinc and retinol-binding protein in acne. Br J Dermatol 96(3):283–286CrossRefPubMedGoogle Scholar
Kim J, Ahn J (2014) Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res 157(2):101–106CrossRefPubMedGoogle Scholar
Kirkil G, Hamdi Muz M, Seckin D, Sahin K, Kucuk O (2008) Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respir Med 102(6):840–844CrossRefPubMedGoogle Scholar
Chimienti F, Aouffen M, Favier A, Seve M (2003) Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets 4(4):323–338CrossRefPubMedGoogle Scholar
de Oliveira KJ, Donangelo CM, de Oliveira AV, da Silveira Jr CL, Koury JC (2009) Effect of zinc supplementation on the antioxidant, copper, and iron status of physically active adolescents. Cell Biochem Funct 27(3):162–166CrossRefPubMedGoogle Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25CrossRefGoogle Scholar
Ramezani Tehrani F, Minooee S, Azizi F (2014) Validation of a simplified method to assess hirsutism in the iranian population. Eur J Obstet Gynecol Reprod Biol 174:91–95CrossRefPubMedGoogle Scholar
Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140(7):815–830PubMedGoogle Scholar
Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L (2000) Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 73(6):1149–1154CrossRefPubMedGoogle Scholar
Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King Jr LE, McMichael AJ (2004) Alopecia areata investigational assessment guidelines—part II. National Alopecia Areata Foundation. J Am Acad Dermatol 51(3):440–447CrossRefPubMedGoogle Scholar
Atsch E, Bochi GV, Pereira Rda S, Kober H, Agertt VA, de Campos MM, Gomes P, Duarte MM, Moresco RN (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44(4):348–350CrossRefGoogle Scholar
Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239(1):70–76CrossRefPubMedGoogle Scholar
Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105(5):581–584PubMedGoogle Scholar
Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9(6):515–540CrossRefPubMedGoogle Scholar
Park H, Kim CW, Kim SS, Park CW (2009) The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level. Ann Dermatol 21(2):142–146CrossRefPubMedPubMedCentralGoogle Scholar
Bhat YJ, Manzoor S, Khan AR, Qayoom S (2009) Trace element levels in alopecia areata. Indian J Dermatol Venereol Leprol 75(1):29–31CrossRefPubMedGoogle Scholar
Lux-Battistelli C (2015) Combination therapy with zinc gluconate and PUVA for alopecia areata totalis: an adjunctive but crucial role of zinc supplementation. Dermatol Ther. doi:10.1111/dth.12215PubMedGoogle Scholar
Sonnichsen N, Reinicke C, Herrmann C, Glatzel E (1984) Zinc therapy of alopecia areata. Dermatol Monatsschr 170(7):437–442PubMedGoogle Scholar
Vivoli G, Fantuzzi G, Bergomi M, Tonelli E, Gatto MR, Zanetti F, Del Dot M (1990) Relationship between zinc in serum and hair and some hormones during sexual maturation in humans. Sci Total Environ 95:29–40CrossRefPubMedGoogle Scholar
Plonka PM, Handjiski B, Popik M, Michalczyk D, Paus R (2005) Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations. Exp Dermatol 14(11):844–853CrossRefPubMedGoogle Scholar
Dias PC, Sena-Evangelista KC, Paiva MS, Ferreira DQ, Ururahy MA, Rezende AA, Abdalla DS, Pedrosa LF (2014) The beneficial effects of rosuvastatin are independent of zinc supplementation in patients with atherosclerosis. J Trace Elem Med Biol 28(2):194–199CrossRefPubMedGoogle Scholar
Kelishadi R, Hashemipour M, Adeli K, Tavakoli N, Movahedian-Attar A, Shapouri J, Poursafa P, Rouzbahani A (2010) Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord 8(6):505–510CrossRefPubMedGoogle Scholar
da Costa CM, Brazao V, Collins Kuehn C, Rodrigues Oliveira LG, do Prado Junior JC, Sala MA, Carraro Abrahao AA (2013) Zinc and pregnancy: marked changes on the immune response following zinc therapy for pregnant females challenged with Trypanosoma cruzi. Clin Nutr 32(4):592–598CrossRefPubMedGoogle Scholar
Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA (2003) Antioxidant effects of zinc supplementation in tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22(4):316–321CrossRefPubMedGoogle Scholar
Shaheen AA, el Fattah AA (1995) Effect of dietary zinc on lipid peroxidation, glutathione, protein thiols levels and superoxide dismutase activity in rat tissues. Int J Biochem Cell Biol 27(1):89–95CrossRefPubMedGoogle Scholar
Tang QQ, Su SY, Fang MY (2014) Zinc supplement modulates oxidative stress and antioxidant values in rats with severe acute pancreatitis. Biol Trace Elem Res 159(1–3):320–324CrossRefPubMedGoogle Scholar
Venneria E, Intorre F, Foddai MS, Azzini E, Palomba L, Raguzzini A, Polito A, Ciarapica D, Zaccaria M (2014) Antioxidant effect of zinc supplementation on both plasma and cellular red-ox status markers in a group of elderly italian population. J Nutr Health Aging 18(4):345–350CrossRefPubMedGoogle Scholar
Gupta S, Ghulmiyyah J, Sharma R, Halabi J, Agarwal A (2014) Power of proteomics in linking oxidative stress and female infertility. Biomed Res Int 2014:916212PubMedPubMedCentralGoogle Scholar
Mier-Cabrera J, Genera-Garcia M, De la Jara-Diaz J, Perichart-Perera O, Vadillo-Ortega F, Hernandez-Guerrero C (2008) Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. Int J Gynaecol Obstet 100(3):252–256CrossRefPubMedGoogle Scholar
Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43(7):1209–1214PubMedGoogle Scholar